After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Third International Conference on Public Health in Africa

The third edition of CPHIA was hosted by the Zambian Ministry of Health and took place from 27th to 30th November 2023 at Mulungushi International Conference Center in Lusaka, Zambia. The topic

Read More

Soap bubbles against coronavirus in Uganda too !

The “Soap bubbles against coronavirus” initiative is sparking interest in other African nations as well. Indeed a group of young Ugandan decided to come together and create a group of

Read More

African-European Symposium: Challenges in Research Ethics Assessment, 13:00 – 18:00 CET, May 25th, 2021.

The symposium,  organised by The Embassy of Good Science, in collaboration with EUREC, BERC-Luso, AfriEthique, and LiberHetica, aims to facilitate the sharing of experiences and perspectives on research ethics assessment challenges between African and

Read More